Healthcare and Pharmaceuticals industry

Global Dermatophytic Onychomycosis Treatment Market Size Share Forecast 2025




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Nail onychomycosis or fungus infection is caused by a fungus called Trichophyton rubrum and Trichophyton mentagrophytes. However, few cases may also be caused by yeasts and molds. Fungi grow and spread due to conditions of warmth and moisture. The infection begins as a white or yellow spot under the tip of the nail and as it spreads deeper into the nail, it causes potentially painful nail discoloration, thickening, and development of crumbling edges. Onychomycosis commonly affects toenails than in fingernails, as toenails are often confined in a dark, warm, moist environment inside shoes where fungi can thrive. Old age people are more likely to be affected by the disease due to suppressed nail growth and immunity, and other complications.
Market Dynamics
Major driver for growth of the dermatophytic onychomycosis treatment market is high prevalence of dermatophytic onychomycosis worldwide. According to a study published in the Journal of the European Academy of Dermatology and Venereology in 2013, the mean prevalence of dermatophytic onychomycosis in Europe and North America was 4.3% in the population-based studies and 8.9% in the hospital-based studies. According to the Centre for Disease Control and Prevention statistics in 2017, around 23 million people in the U.S. are affected by this disease each year.
Increasing geriatric population across the globe is another major factor driving growth of the market. According to the Population Prospects report by the United Nations, the number of people aged 60 years and above would reach 1.3 billion by 2025.
Key features of the study:

This report provides in-depth analysis of dermatophytic onychomycosis treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2018 – 2026), considering 2017, as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global dermatophytic onychomycosis treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Bausch Health Companies, Galderma S.A., Celtic Pharma, Anacor Pharmaceuticals, Inc., Johnson & Johnson, Novartis AG, Pfizer Inc, GlaxoSmithKline, Topica Pharmaceuticals, Inc., Moberg Pharma AB, Bayer AG, Dr. Reddy’s Laboratories Ltd, Allergen, Inc., Cipla Ltd, Medimetriks Pharmaceuticals Inc., Sanofi S.A., NovaBiotics Inc., and Merz Pharma
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global dermatophytic onychomycosis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the dermatophytic onychomycosis treatment market

Detailed Segmentation:

Global Dermatophytic Onychomycosis Treatment Market, By Therapy Type:

Systemic Therapy
Topical Therapy
Device-based Therapy

Global Dermatophytic Onychomycosis Treatment Market, By End User:

Hospitals
Dermatology Clinics
Retail Pharmacies
Others

Global Dermatophytic Onychomycosis Treatment Market, By Geography:

North America

By Therapy Type

Systemic Therapy
Topical Therapy
Device-based Therapy

By End Users

Hospitals
Dermatology Clinics
Retail Pharmacies
Others

By Country:

U.S.
Canada


Latin America

By Therapy Type

Systemic Therapy
Topical Therapy
Device-based Therapy

By End Users

Hospitals
Dermatology Clinics
Retail Pharmacies
Others

By Country:

Brazil
Mexico
Argentina
Rest of Latin America


Europe

By Therapy Type

Systemic Therapy
Topical Therapy
Device-based Therapy

By End Users

Hospitals
Dermatology Clinics
Retail Pharmacies
Others

By Country:

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe


Asia Pacific

By Therapy Type

Systemic Therapy
Topical Therapy
Device-based Therapy

By End Users

Hospitals
Dermatology Clinics
Retail Pharmacies
Others

By Country:

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific


Middle East

By Therapy Type

Systemic Therapy
Topical Therapy
Device-based Therapy

By End Users

Hospitals
Dermatology Clinics
Retail Pharmacies
Others

By Country:

GCC
Israel
Rest of Middle East


Africa

By Therapy Type

Systemic Therapy
Topical Therapy
Device-based Therapy

By End Users

Hospitals
Dermatology Clinics
Retail Pharmacies
Others

By Country:

South Africa
Central Africa
North Africa



Company Profiles

Bausch Health Companies *

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies

Novartis AG
Johnson and Johnson
Galderma S.A.,
Anacor Pharmaceuticals
Celtic Pharmaceuticals
GlaxoSmithKline
Pfizer Inc
Moberg Pharma AB


“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Therapy Type
o Market Devices, By End User
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o New Product Launches
o Mergers and Acquisitions
o Regulatory Scenario
o Reimbursement Scenario
o PEST Analysis
o Pipeline Analysis
4. Global Dermatophytic Onychomycosis Treatment Market, By Therapy Type, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2017 and 2025 (%)
o Y-o-Y Growth Analysis, 2018 - 2026
o Segment Trends
o Systemic Therapy
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
o Topical Therapy
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
o Device-based Therapy
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
5. Global Dermatophytic Onychomycosis Treatment Market, By End User, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2017 and 2026 (%)
o Y-o-Y Growth Analysis, 2018 - 2026
o Segment Trends
o Hospitals
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
o Dermatology Clinics
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
o Retail Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
6. Global Dermatophytic Onychomycosis Treatment Market, By Region, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2017 and 2026 (%)
o Y-o-Y Growth Analysis, For Regions, 2018 - 2026
o North America
o Market Size and Forecast, By Therapy Type, 2018 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
o U.S.
o Canada
o Latin America
o Market Size and Forecast, By Therapy Type, 2018 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
o Market Size and Forecast, By Therapy Type, 2018 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Therapy Type, 2018 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2018-2026, (US$ Million)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of APAC
o Middle East
o Market Size and Forecast, By Therapy Type, 2018 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2018-2026, (US$ Million)
o GCC
o Israel
o Rest of Middle East
o Africa
o Market Size and Forecast, By Therapy Type, 2018 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2018-2026, (US$ Million)
o South Africa
o Central Africa
o North Africa
7. Competitive Landscape
o Market Share Analysis
o Company Profiles
o Bausch Health Companies*
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Galderma SA
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Celtic Pharma
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Anacor pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Johnson & Johnson
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Novartis AG
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Topica Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o GlaxoSmithKline
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Pfizer, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Analyst Views
8. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 19 market data tables and 23 figures on "Dermatophytic Onychomycosis Treatment Market" - Global forecast to 2026".

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.